After including TNM stage and THADA expression together in a multifactorial survival analysis, both high TNM stage (P=0.008) and low THADA expression (P=0.038) were found to be independent poor prognostic factors for GC patients receiving postoperative 5-FU adjuvant chemotherapy (Table 1). The gene discussed is THADA; the disease is gastric cancer.